Recabo, Baby Boy .

HRN: 23-45-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
AMPICILLIN 250MG (VIAL)
09/10/2023
09/17/2023
IV
100mg
Q12hrs
Prematurity
Waiting Final Action 
09/10/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
09/10/2023
09/17/2023
IV
10mg
Q24
Prematurity
Waiting Final Action 
09/13/2023
CEFTAZIDIME 1GM (VIAL)
09/13/2023
09/20/2023
IV
100 Mg
Every 12 Hours
Neonatal Sepsis
Checking Final Appropriateness 
09/22/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/22/2023
09/29/2023
ORAL
30mg And 12mg
OD
Prematurity
Waiting Final Action 
09/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/22/2023
09/29/2023
IV
190mg
BID
Prematurity
Waiting Final Action 
09/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/22/2023
09/29/2023
IV
29mg
Q36
Prematurity
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: